These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6343032)
1. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects. Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032 [TBL] [Abstract][Full Text] [Related]
2. The clinical pharmacology of human insulin (Novo) in normal subjects. Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG Diabetes Care; 1983; 6 Suppl 1():13-6. PubMed ID: 6133710 [TBL] [Abstract][Full Text] [Related]
3. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects. Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781 [TBL] [Abstract][Full Text] [Related]
4. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin. Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554 [TBL] [Abstract][Full Text] [Related]
5. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration. Schatz H; Ammermann S Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man. Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man. Home PD; Shepherd GA; Noy G; Massi-Benedetti M; Hanning I; Burrin JM; Alberti KG Diabetes Care; 1983; 6 Suppl 1():23-8. PubMed ID: 6343033 [TBL] [Abstract][Full Text] [Related]
8. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection. Schatz H; Ammermann S; Laube H; Federlin K Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients. Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs. Plum A; Agerso H; Andersen L Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy. Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035 [TBL] [Abstract][Full Text] [Related]
12. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of five pre-mixed combinations of 'short-' and 'intermediate-acting' (NPH) insulins in healthy subjects following subcutaneous administration. Owens DR; Jones AL; Dolben J; Dean JD; Petocz P; Coates PA; Luzio SD Diabetes Res; 1993; 22(2):77-86. PubMed ID: 8205740 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas. Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037 [TBL] [Abstract][Full Text] [Related]
15. Semisynthetic human insulin: biological and pharmacokinetic effects in normal subjects. Brogard JM; Paris-Bockel D; Blickle JF; Cohen B; Pinget M; Stahl A Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):238-43. PubMed ID: 3298081 [TBL] [Abstract][Full Text] [Related]
16. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers. Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of human insulin of recombinant DNA origin in healthy volunteers. Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Tarui S Diabetes Care; 1982; 5 Suppl 2():35-8. PubMed ID: 6765537 [TBL] [Abstract][Full Text] [Related]
18. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of porcine and human regular insulins using an artificial pancreas]. Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J; Monnier L Nouv Presse Med; 1982 Nov; 11(45):3331-3. PubMed ID: 6760120 [TBL] [Abstract][Full Text] [Related]
20. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins. George E; Bedford C; Peacey SR; Hardisty CA; Heller SR Diabet Med; 1997 Jun; 14(6):442-8. PubMed ID: 9212308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]